Serious bleeding and embolic events are common after fibrinolytic therapy (FT) for left-sided prosthetic valve thrombosis (PVT), and are believed to occur more frequently with prolonged fibrinolytic infusions. But there is no data from prospective studies examining this contention. Our aim was to determine the timing of adverse events after FT with streptokinase (SK) for left-sided PVT. In a post-hoc analysis involving all 120 participants from a randomized controlled trial of FT for left-sided PVT, we determined the timing of occurrence of a composite of death, major bleeding, embolic stroke, or non-central nervous system systemic embolism, in relation to the duration of SK infusion. The composite outcome occurred in 20 (16.7%) of the 120 patients. Adverse events were more frequent within 12 h of initiating treatment than later (28% vs. 10%; OR 3.75, 95% CI 1.25–11.20, P = 0.018). Contrary to current thinking, adverse events can occur early during fibrinolytic therapy for left-sided PVT. This has important implications for the use of fibrinolysis as first line treatment for left-sided PVT.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Reddy NK, Padmanabhan TN, Singh S, Kumar DN, Raju PR, Satyanarayana PV, Rao DP, Rajagopal P, Raju BS (1994) Thrombolysis in left-sided prosthetic valve occlusion: immediate and follow-up results. Ann Thorac Surg 58:462–470 Discussion 470-1
Rajasekhar D, Balakrishnan KG, Venkitachalam CG, Tharakan JA, Titus T, Pillai VR, Kumar VK, Bhat A (1994) Thrombolytic therapy for prosthetic cardiac valve thrombosis. Indian Heart J 46:101–105
Gupta D, Kothari SS, Bahl VK, Goswami KC, Talwar KK, Manchanda SC, Venugopal P (2000) Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results. Am Heart J 140:906–916
Balasundaram RP, Karthikeyan G, Kothari SS, Talwar KK, Venugopal P (2005) Fibrinolytic treatment for recurrent left sided prosthetic valve thrombosis. Heart 91:821–822
Karthikeyan G, Math RS, Mathew N, Shankar B, Kalaivani M, Singh S, Bahl VK, Hirsh J, Eikelboom JW (2009) Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation 120:1108–1114
Lengyel M, Fuster V, Keltai M, Roudaut R, Schulte HD, Seward JB, Chesebro JH, Turpie AG (1997) Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol 30:1521–1526
Roudaut R, Roques X, Lafitte S, Choukroun E, Laborde N, Madona F, Deville C, Baudet E (2003) Surgery for prosthetic valve obstruction. A single center study of 136 patients. Eur J Cardiothorac Surg 24:868–872
Deviri E, Sareli P, Wisenbaugh T, Cronje SL (1991) Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 17:646–650
Renzulli A, Onorati F, De Feo M, Vitale N, Esposito S, Agozzino L, Santarpino G, Mastroroberto P, Marchese AR, De Luca L, Scardone M, Cotrufo M (2004) Mechanical valve thrombosis: a tailored approach for a multiplex disease. J Heart Valve Dis 13(Suppl 1):S37–S42
Roudaut R, Lafitte S, Roudaut MF, Reant P, Pillois X, Durrieu-Jais C, Coste P, Deville C, Roques X (2009) Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis 102:269–277
About this article
Cite this article
Karthikeyan, G., Mathew, N., Math, R.S. et al. Timing of adverse events during fibrinolytic therapy with streptokinase for left-sided prosthetic valve thrombosis. J Thromb Thrombolysis 32, 146–149 (2011). https://doi.org/10.1007/s11239-011-0579-4
- Prosthetic valve thrombosis
- Adverse events